208 related articles for article (PubMed ID: 29682785)
1. Bayesian propensity scores for high-dimensional causal inference: A comparison of drug-eluting to bare-metal coronary stents.
Spertus JV; Normand ST
Biom J; 2018 Jul; 60(4):721-733. PubMed ID: 29682785
[TBL] [Abstract][Full Text] [Related]
2. Estimation of causal effects of multiple treatments in observational studies with a binary outcome.
Hu L; Gu C; Lopez M; Ji J; Wisnivesky J
Stat Methods Med Res; 2020 Nov; 29(11):3218-3234. PubMed ID: 32450775
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian nonparametric approach to causal inference on quantiles.
Xu D; Daniels MJ; Winterstein AG
Biometrics; 2018 Sep; 74(3):986-996. PubMed ID: 29478267
[TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries.
Hsieh MJ; Chen CC; Chang SH; Wang CY; Lee CH; Lin FC; Chang CJ; Hsieh IC
Int J Cardiol; 2013 Oct; 168(4):3785-90. PubMed ID: 23830345
[TBL] [Abstract][Full Text] [Related]
6. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
Linden A
J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
[TBL] [Abstract][Full Text] [Related]
7. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
[TBL] [Abstract][Full Text] [Related]
8. Midterm outcomes of bare-metal stenting after primary stenting for ST-segment elevated myocardial infarctions in the drug-eluting stent era: a propensity score-matched comparison with sirolimus-eluting stent.
Nakata K; Ishikawa T; Nakano Y; Yoshimura M; Mutoh M
Cardiovasc Interv Ther; 2015 Jul; 30(3):234-43. PubMed ID: 25420640
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis.
Paradis JM; Bélisle P; Joseph L; Bertrand OF; DeLarochellière R; Déry JP; Larose E; Rodés-Cabau J; Rinfret S
Circ Cardiovasc Interv; 2010 Dec; 3(6):565-76. PubMed ID: 21098743
[TBL] [Abstract][Full Text] [Related]
10. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
[TBL] [Abstract][Full Text] [Related]
11. Comparing methods for estimation of heterogeneous treatment effects using observational data from health care databases.
Wendling T; Jung K; Callahan A; Schuler A; Shah NH; Gallego B
Stat Med; 2018 Oct; 37(23):3309-3324. PubMed ID: 29862536
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Robinson SD; Siega AD;
Catheter Cardiovasc Interv; 2016 Jul; 88(1):24-35. PubMed ID: 26945680
[TBL] [Abstract][Full Text] [Related]
13. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis.
Jaguszewski M; Ghadri JR; Seifert B; Hiestand T; Herrera P; Gaemperli O; Landmesser U; Maier W; Nallamothu BK; Windecker S; Lüscher TF; Templin C
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):220-9. PubMed ID: 24979116
[TBL] [Abstract][Full Text] [Related]
15. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
16. Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: post-hoc analysis of the PASSION-trial.
Vink MA; Dirksen MT; Tijssen JG; Suttorp MJ; Patterson MS; van Geloven N; Ijsselmuiden AJ; Slagboom T; Kiemeneij F; Laarman GJ
Catheter Cardiovasc Interv; 2012 May; 79(6):870-7. PubMed ID: 21735533
[TBL] [Abstract][Full Text] [Related]
17. Time dependent effect on mortality of drug-eluting stents versus bare metal stents.
Mølstad P
Scand Cardiovasc J; 2012 Aug; 46(4):226-32. PubMed ID: 22462392
[TBL] [Abstract][Full Text] [Related]
18. Bare Metal Versus Paclitaxel-Eluting Stents for Long Femoropopliteal Lesions: Prospective Cohorts Comparison Using a Propensity Score-Matched Analysis.
Vent PA; Kaladji A; Davaine JM; Guyomarch B; Chaillou P; Costargent A; Quillard T; Gouëffic Y
Ann Vasc Surg; 2017 Aug; 43():166-175. PubMed ID: 28300676
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study.
Austin D; Oldroyd KG; McConnachie A; Slack R; Eteiba H; Flapan AD; Jennings KP; Northcote RJ; Pell AC; Starkey IR; Pell JP
Circ Cardiovasc Interv; 2008 Aug; 1(1):45-52. PubMed ID: 20031654
[TBL] [Abstract][Full Text] [Related]
20. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
